Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Role of photodynamic therapy in unresectable esophageal and lung cancer Chen M; Pennathur A; Luketich JDLasers Surg Med 2006[Jun]; 38 (5): 396-402The incidence of esophageal cancer has increased dramatically in the Western population in the last two decades. Many of these patients tend to present late in the disease course with symptoms of dysphagia and malnutrition. Thus a majority of patients at presentation may require palliation of their symptoms. Lung cancer is the most common cause of cancer related mortality in the United States. Similar to esophageal cancer, many patients present in advanced stages where surgical resection for cure may not be an option. Endobronchial obstruction from both primary and metastatic neoplasm causes significant morbidity. The modalities, which are currently available for palliation of symptoms include surgery, photodynamic therapy, dilation, external beam radiation, stents, Nd:YAG laser therapy, and brachytherapy. Each of these modalities has their specific advantages and drawbacks. In this article, we discuss the role of photodynamic therapy in the palliation of esophageal and lung cancer.|*Photochemotherapy/adverse effects[MESH]|Airway Obstruction/drug therapy/etiology[MESH]|Deglutition Disorders/drug therapy/etiology[MESH]|Dihematoporphyrin Ether/*therapeutic use[MESH]|Esophageal Neoplasms/complications/*drug therapy[MESH]|Hemoptysis/drug therapy/etiology[MESH]|Humans[MESH]|Lung Neoplasms/complications/*drug therapy[MESH]|Palliative Care[MESH]|Photosensitizing Agents/*therapeutic use[MESH] |